Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Operating activities:
Net income	$ 51,344	$ 56,126
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,873	1,764
Change in deferred income taxes	4,654	(1,043)
Change in payable to related parties pursuant to tax receivable agreement	(883)	0
Equity-based compensation	2,846	1,897
Equity in (income) loss of investees	(11,866)	625
Net realized loss on sale of investments	288	0
Fair value adjustment of investments	(757)	(4,344)
Proceeds received from partnerships	6,060	3,343
Non-cash lease expense	2,062	1,374
Other	36	14
Changes in operating assets and liabilities:
Fees receivable	(18,725)	6,887
Prepaid expenses	1,809	283
Due from related parties	(777)	(1,908)
Other assets	17,389	1,128
Accounts payable	1,015	743
Accrued compensation and benefits	8,336	16,807
Lease liability	(1,954)	(1,819)
Other liabilities	(1,402)	(18,241)
Consolidated variable interest entities related:
Net cash provided by operating activities	57,973	60,952
Investing activities:
Purchase of furniture, fixtures and equipment	(3,385)	(1,707)
Cash paid for acquisition of business	0	(1,500)
Purchase of investments	(1,177)	(20,236)
Proceeds from sale of investments	1,343	0
Proceeds from sale of intangible assets	876	0
Distributions received from Partnerships	1,676	2,227
Contributions to Partnerships	(22,686)	(35,237)
Net cash used in investing activities	(39,722)	(56,453)
Financing activities:
Borrowings of debt	0	25,000
Repayments of debt	(625)	(457)
Draw-down on revolver	10,000	25,000
Repayment of revolver	(25,000)	0
Repurchase of Class A shares for employee tax withholding	(108)	0
Proceeds received from issuance of shares under Employee Share Purchase Plan	551	485
Dividends paid	(15,049)	(12,947)
Members’ distributions paid	(18,423)	(30,485)
Consolidated variable interest entities related:
Net cash (used in) provided by financing activities	(4,834)	6,496
Increase in cash and cash equivalents, restricted cash, and cash and cash equivalents held at consolidated variable interest entities	13,417	10,995
Cash and cash equivalents, restricted cash, and cash and cash equivalents held at consolidated variable interest entities at beginning of the period	116,552	76,197
Cash and cash equivalents, restricted cash, and cash and cash equivalents held at consolidated variable interest entities at end of the period	129,969	87,192
Reconciliation of Cash and Cash Equivalents, Restricted Cash and Cash and Cash Equivalents Held at Consolidated Variable Interest Entities to the Condensed Consolidated Balance Sheets:
Total cash and cash equivalents, restricted cash, and cash and cash equivalents held at consolidated variable interest entities	129,969	87,192
Consolidated VIEs
Adjustments to reconcile net income to net cash provided by operating activities:
Fair value adjustment of investments	(794)	(1,966)
Consolidated variable interest entities related:
Change in warrant liability measured at fair value	0	(1,966)
Equity in income of investees	(132)	(732)
Other assets and liabilities	(3,243)	14
Investing activities:
Purchase of investments	(16,369)	0
Consolidated variable interest entities related:
Contributions from non-controlling interest in general partnerships	148	133
Distributions to non-controlling interest in general partnerships	(22)	(233)
Contributions from non-controlling interest in consolidated funds	43,694	0
Reconciliation of Cash and Cash Equivalents, Restricted Cash and Cash and Cash Equivalents Held at Consolidated Variable Interest Entities to the Condensed Consolidated Balance Sheets:
Cash and cash equivalents	24,909	144
Consolidated Entity Excluding Variable Interest Entities (VIE)
Reconciliation of Cash and Cash Equivalents, Restricted Cash and Cash and Cash Equivalents Held at Consolidated Variable Interest Entities to the Condensed Consolidated Balance Sheets:
Cash and cash equivalents	100,255	83,052
Restricted cash	$ 4,805	$ 3,996